Current Cardiology Reviews
Title:What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia?
Volume: 17 Issue: 2
Author(s): Federico Cacciapuoti*
Affiliation:
- Department of Internal Medicine, “L. Vanvitelli” Campania University-Naples,Italy
Export Options
About this article
Cite this article as:
Cacciapuoti Federico *, What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia?, Current Cardiology Reviews 2021; 17 (2) . https://dx.doi.org/10.2174/1573403X16666200511085701
DOI https://dx.doi.org/10.2174/1573403X16666200511085701 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Risk Stratification in Pulmonary Embolism
Current Respiratory Medicine Reviews Plasminogen Activator Inhibitor-1 in Vascular Thrombosis
Current Drug Targets Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases
Current Pharmaceutical Design Renal Artery Stenting: Efficacy and Complications
Current Hypertension Reviews Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis
Current Drug Delivery NOAC in Acute Coronary Syndrome and AF?
Cardiovascular & Hematological Disorders-Drug Targets Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors
Current Drug Targets Infrequent Infections in COPD
Current Respiratory Medicine Reviews Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research Smoking and Cardiovascular System: Cellular Features of the Damage
Current Pharmaceutical Design Editorial [Hot Topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Hypertension-Related Disorders (Executive Guest Editor: Aurelio Leone)]
Current Pharmaceutical Design Turning Up the Pressure on Vascular Disease
Current Neurovascular Research Catatonia: A Brief Update
Current Psychiatry Reviews Renal Venous Thrombosis in Neonates
Current Pediatric Reviews Endovascular Therapeutic Embolisation: An Overview of Occluding Agents and their Effects on Embolised Tissues
Current Vascular Pharmacology Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT)
Current Drug Therapy Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design Advances in Inhibitors of FXa
Current Drug Targets